Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS: We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS: The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS: Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence shows risk at lower doses (<0.5 Gy), with an estimated latency of 10 years or more29–31.”
From Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars (2020) · cites this paper as [29]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
(2011) · The Lancet · doi:10.1016/s0140-6736(11)61629-2 · Cited by 3,937
Self-citationCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
The completeness of the Swedish Cancer Register – a sample survey for year 1998
Barlow, L., Westergren, K., Holmberg, L., & Talbäck, M. (2009) · Acta Oncologica · doi:10.1080/02841860802247664 · Cited by 1,236
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationDarby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Self-citationLifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Jones B, 2001, Clin Oncol (R Coll Radiol), 13, 71
Cited by
Items 201–300 of 1,001
Yegya‐Raman, N., Wang, K., Kim, S., Reyhan, M. L., Deek, M. P., Sayan, M., Li, D., Patel, M. M., Malhotra, J. D., Aisner, J., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.028 · Cited by 116
Yeung, R. H., Conroy, L., Long, K., Walrath, D., Li, H., Smith, W. L., Hudson, A., & Phan, T. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0511-8 · Cited by 113
“Although there is evidence to suggest no safe threshold dose to the heart, the proposed dose of <4 Gy served as a reference to enable comparison in the current study [4,23].”
BackgroundAzimzadeh, O., Sievert, W., Sarioglu, H., Merl-Pham, J., Yentrapalli, R., Bakshi, M. V., Janik, D., Ueffing, M., Atkinson, M. J., Multhoff, G., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr501141b · Cited by 108
Mulliez, T., Veldeman, L., Greveling, A. V., Speleers, B., Sadeghi, S., Berwouts, D., Decoster, F., Vercauteren, T., Gersem, W. D., den Broecke, R. V., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.08.040 · Cited by 120
“[6] showed a linear relationship between mean heart dose and rates of ischemic heart disease starting within a few years and continuing decades after breast RT.”
BackgroundInfluentialPrevention of Cardiovascular Disease in Women
Saeed, A., Kampangkaew, J., & Nambi, V. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-4-185 · Cited by 130
Bradley, J. A., Dagan, R., Ho, M. W., Rutenberg, M. S., Morris, C. G., Li, Z., & Mendenhall, N. P. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.09.018 · Cited by 112
Dose-Escalation Study for Cardiac Radiosurgery in a Porcine Model
Blanck, O., Bode, F., Gebhard, M., Hunold, P., Brandt, S., Bruder, R., Großherr, M., Vonthein, R., Rades, D., & Dunst, J. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.02.036 · Cited by 117
Rethinking the Standard for Ductal Carcinoma In Situ Treatment
Esserman, L. J., & Yau, C. S. F. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2607 · Cited by 111
Ionizing radiation and atherosclerosis: Current knowledge and future challenges
Borghini, A., Gianicolo, E., Picano, E., & Andreassi, M. G. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.010 · Cited by 118
Rusthoven, C. G., Rabinovitch, R., Jones, B. L., Koshy, M., Amini, A., Yeh, N., Jackson, M. W., & Fisher, C. M. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw046 · Cited by 109
“Additionally, to account for the potential impact of unmeasured cardiac effects from RT [12], a subgroup analysis evaluating the impact of RT for right- versus left-sided breast cancers was carried out, which demonstrated no significant interactions between PMRT or RNI and tumor laterality (supplementary material, ava…”
BackgroundContreras, J. A., Lin, A. J., Weiner, A. A., Speirs, C. K., Samson, P. P., Mullen, D. F., Campian, J. L., Bradley, J. D., Roach, M. C., & Robinson, C. G. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.05.017 · Cited by 110
Petersen, P. M., Aznar, M. C., Berthelsen, A. K., Loft, A., Schut, D. A., Maraldo, M. V., Josipović, M., Klausen, T. L., Andersen, F. L., & Specht, L. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.932435 · Cited by 109
Jimenez, R., Hickey, S. B., Depauw, N., Yeap, B. Y., Batin, E., Gadd, M. A., Specht, M. C., Isakoff, S. J., Smith, B. L., Liao, E. C.-W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02366 · Cited by 108
“Cardiac exposure to RT has been shown to increase the risk of major cardiac events with risk proportional to mean heart RT dose.(5,6) Recently, there has been significant public interest in the cardiovascular risks of breast cancer therapy and strategies to mitigate these risks.”
BackgroundReview of Deep Learning Based Automatic Segmentation for Lung Cancer Radiotherapy
Liu, X., Li, K., Yang, R., & Geng, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.717039 · Cited by 122
O'Shea, T. P., Bamber, J. C., Fontanarosa, D., van der Meer, S., Verhaegen, F., & Harris, E. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/8/r90 · Cited by 108
“No decrease in strain rate could be observed in segments that received less than 3 Gy but this may be due to the sensitivity of the technique rather than a lack of effect (Darby et al 2013).”
BackgroundThe Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study
Lega, I. C., Austin, P. C., Fischer, H. D., Fung, K., Krzyzanowska, M. K., Amir, E., & Lipscombe, L. L. (2018) · Diabetes Care · doi:10.2337/dc17-2012 · Cited by 115
Stuart, K. E., Houssami, N., Taylor, R. J., Hayen, A. D., & Boyages, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1904-7 · Cited by 119
“Scandinavian data detected the rate of major coronary events was proportional to mean heart dose [42]; with improved homogeneity of radiation dosing using 3D and 4D computed tomography planning and intensitymodulated radiation therapy, a decrease in late toxicity is expected [43–45].”
BackgroundNovel Radiotherapy Techniques for Breast Cancer
Bradley, J. A., & Mendenhall, N. P. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-042716-103422 · Cited by 105
Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation
Jumeau, R., Özşahin, M., Schwitter, J., Vallet, V., Duclos, F., Zeverino, M., Moeckli, R., Pruvot, E. J., & Bourhis, J. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.04.025 · Cited by 105
The Cardiovascular System in Space: Focus on In Vivo and In Vitro Studies
Baran, R., Marchal, S., Campos, S. G., Rehnberg, E., Tabury, K., Baselet, B., Wehland, M., Grimm, D. G., & Baatout, S. (2021) · Biomedicines · doi:10.3390/biomedicines10010059 · Cited by 117
“There was a significantly increased risk of RICVD in a cohort of Russian emergency workers of the Chernobyl accidents who were exposed to doses as low as 1.15 Gy [50].”
BackgroundInfluentialCardiometabolic Comorbidities in Cancer Survivors
Zullig, L. L., Sung, A. D., Khouri, M. G., Jazowski, S. A., Shah, N. P., Sitlinger, A. P., Blalock, D. V., Whitney, C. A., Kikuchi, R., Bosworth, H. B., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.03.005 · Cited by 122
Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice
Shah, C., Al-Hilli, Z., & Vicini, F. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00635 · Cited by 105
Ranger, A., Dunlop, A., Hutchinson, K., Convery, H. M., Maclennan, M. K., Chantler, H., Twyman, N., Rose, C., Mcquaid, D., Amos, R. A., et al. (2018) · Clinical Oncology · doi:10.1016/j.clon.2018.01.017 · Cited by 108
“Although the MHD is the only parameter on which a dose-effect relationship has been reported [7], it is conceivable that this is a surrogate for doses to the anterior part of the heart (which are more specifically reflected in the heart V17 Gy and LAD doses), in”
BackgroundGilchrist, S. C., Jones, L. W., Krone, R. J., Stein, P. K., & Scott, J. M. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.05.014 · Cited by 109
Cardiovascular Disease in Women: From Pathophysiology to Novel and Emerging Risk Factors
Geraghty, L. E., Figtree, G. A., Schutte, A. E., Patel, S., Woodward, M., & Arnott, C. G. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.05.108 · Cited by 110
Kim, K. H., Oh, J., Yang, G., Lee, J., Kim, J., Gwak, S., Cho, I., Lee, S., Byun, H. K., Choi, H., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.4202 · Cited by 108
Verma, V., Simone, C. B., & Werner‐Wasik, M. (2017) · Cancers · doi:10.3390/cancers9090120 · Cited by 107
Rehammar, J. C., Jensen, M., McGale, P., Lorenzen, E. L., Taylor, C., Darby, S. C., Videbæk, L. M., Wang, Z., & Ewertz, M. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.03.012 · Cited by 102
Self-citationCardiovascular Complications of Radiotherapy
Lee, M. S., Finch, W., & Mahmud, E. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.07.031 · Cited by 106
“Although regurgitation is more common than stenosis after radiotherapy, stenosis is more likely to be clinically relevant.(2,9,68,69) The tricuspid and pulmonary valves are less commonly affected.”
InfluentialProton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy
Doyen, J., Falk, A. T., Floquet, V., Hérault, J., & Hannoun‐Lévi, J. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.12.007 · Cited by 102
“This benefit on overall survival was not observed in earlier studies because of very long term cardiovascular toxicities [19] and second cancers [20] induced by radiation therapy.”
BackgroundCardiac substructure segmentation with deep learning for improved cardiac sparing
Morris, E. D., Ghanem, A. I., Dong, M., Pantelic, M., Walker, E., & Glide‐Hurst, C. K. (2019) · Medical Physics · doi:10.1002/mp.13940 · Cited by 106
“7 Despite having whole-heart dose limits, evidence suggests that dose to sensitive cardiac substructures may lead to cardiac toxicities 4,8,9 including cardiomyopathy, CAD, as well as pericardial, and conduction system diseases.”
BackgroundRadiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment
Spetz, J., Moslehi, J., & Sarosiek, K. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0627-x · Cited by 96
Clinical Features of Radiation-induced Carotid Atherosclerosis
Gujral, D. M., Shah, B. N., Chahal, N., Senior, R., Harrington, K. J., & Nutting, C. M. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.10.002 · Cited by 104
Jain, D., Russell, R. R., Schwartz, R. G., Panjrath, G. S., & Aronow, W. S. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0846-x · Cited by 114
Chang, C.-L., Tsai, H., Lin, W.-C., Chang, J., Hsu, H.-L., Chow, J., Yuan, K. S., Wu, A. T. H., & Wu, S. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.08.025 · Cited by 99
Zureick, A. H., Grzywacz, V. P., Almahariq, M. F., Silverman, B. R., Vayntraub, A., Chen, P. Y., Gustafson, G. S., Jawad, M. S., & Dilworth, J. T. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.04.019 · Cited by 99
Sardar, P., Kundu, A., Chatterjee, S., Nohria, A., Nairooz, R. S., Bangalore, S., Mukherjee, D., Aronow, W. S., & Lavie, C. J. (2016) · Clinical Cardiology · doi:10.1002/clc.22631 · Cited by 109
“4% per Gy, with no clear threshold.(6) Unfortunately, details regarding individual cardiac radiation doses were not FIGURE 1 Forest plot for cardiac mortality; left- vs right-sided RT for breast cancer.”
BackgroundMethodInfluentialPark, N.-J., Chang, Y., Bender, C. M., Conley, Y. P., Chlebowski, R. T., Londen, G. J. V., Foraker, R. E., Wassertheil-Smoller, S. W., Stefanick, M. L., & Kuller, L. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184174 · Cited by 108
Global democratisation of proton radiotherapy
Yan, S., Ngoma, T. A., Ngwa, W. F., & Bortfeld, T. R. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00184-5 · Cited by 102
DEGRO practical guidelines for radiotherapy of breast cancer IV
Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO), Wenz, F. K., Sperk, E., Budach, W., Dunst, J., Feyer, P., Fietkau, R., Haase, W., Harms, W., Piroth, M. D., et al. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-014-0687-0 · Cited by 98
Cardiovascular disease in cancer survivors
Okwuosa, T. M., Anzevino, S., & Rao, R. (2017) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134417 · Cited by 97
Patti, G., Caterina, R. D., Abbate, R., Andreotti, F., Biasucci, L. M., Calabrò, P., Cioni, G., Davì, G., Sciascio, G. D., Golia, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu279 · Cited by 101
Rassaf, T., Totzeck, M., Backs, J., Bokemeyer, C., Hallek, M. J., Hilfiker‐Kleiner, D., Hochhaus, A., Lüftner, D., Müller, O. J., Neudorf, U., et al. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01636-7 · Cited by 98
Cuaron, J. J., Chon, B. H., Tsai, H. K., Goenka, A., DeBlois, D., Ho, A. Y., Powell, S. N., Hug, E. B., & Cahlon, O. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.01.005 · Cited by 97
“Darby et al (7) recently demonstrated a linear correlation between the mean dose to the heart and subsequent rates of ischemic heart disease among a large cohort of patients treated with conventional radiation therapy for breast cancer, without any apparent threshold.”
BackgroundSimonetto, C., Eidemüller, M., Gaasch, A., Pazos, M., Schönecker, S., Reitz, D., Kääb, S., Braun, M., Harbeck, N., Niyazi, M., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.07.024 · Cited by 97
New frontiers in proton therapy: applications in cancers
Yuan, T., Zhan, Z., & Qian, C. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0407-3 · Cited by 96
“However, long term cardiovascular toxicities and second cancers induced by radiation therapy will counteract the benefit on OS [27, 28].”
BackgroundWhole breast proton irradiation for maximal reduction of heart dose in breast cancer patients
Mast, M. E., Vredeveld, E. J., Credoe, H. M., van Egmond, J., Heijenbrok, M. W., Hug, E. B., Kalk, P., van Kempen-Harteveld, L., Korevaar, E. W., van der Laan, H. P., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3149-6 · Cited by 103
“[24] approximated the increased rate of absolute radiation-induced ischemic heart disease by using the tables of the Darby publication [6].”
BackgroundMethodInfluentialVasyuk, Y. A., Gendlin, G. E., Emelina, E. I., Shupenina, E. Y., Ballyuzek, M. F., Баринова, И. В., Vitsenya, M. V., Davydkin, I. L., Петрович, Д. Д., Duplyakov, D. V., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4703 · Cited by 97
Rochet, N., Drake, J. I., Harrington, K., Wolfgang, J. A., Napolitano, B. N., Sadek, B. T., Shenouda, M. N., Keruakous, A. R., Niemierko, A., & Taghian, A. G. (2014) · Practical Radiation Oncology · doi:10.1016/j.prro.2014.08.003 · Cited by 94
Shiraishi, Y., Xu, C., Yang, J., Komaki, R. U., & Lin, S. H. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.034 · Cited by 94
Clinical Trial Strategies to Compare Protons With Photons
Langendijk, J. A., Boersma, L. J., Rasch, C. R. N., van Vulpen, M., Reitsma, J. B., van der Schaaf, A., & Schuit, E. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2017.11.008 · Cited by 95
“For certain complications, other study designs may be appropriate (eg, nested case control studies), such as complications with very long latency times like cardiac complications after breast cancer radiotherapy or secondary tumor induction.(13,14) (2) The number of patients and events should be sufficient.”
BackgroundThe Role of Mitochondrial Dysfunction in Radiation-Induced Heart Disease: From Bench to Bedside
Livingston, K., Schlaak, R. A., Puckett, L. L., & Bergom, C. R. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00020 · Cited by 96
“Cardiac events occurred within the first 5 years and continued several decades post-radiotherapy (7).”
BackgroundLittle, M. P., Azizova, T. V., & Hamada, N. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1876955 · Cited by 108
“5Gy, which we have not considered, are also generally consistent with those in populations exposed at the much lower doses/dose rates discussed above (Mulrooney et al. 2009; Little, Azizova, et al. 2012; Little, Kleinerman, et al. 2012; Darby et al. 2013; Little et al. 2013).”
BackgroundResultInfluentialThe Effects of Ionising and Non-Ionising Electromagnetic Radiation on Extracellular Matrix Proteins
Tuieng, R. J., Cartmell, S. H., Kirwan, C., & Sherratt, M. J. (2021) · Cells · doi:10.3390/cells10113041 · Cited by 112
Murphy, M. C., Wrobel, M. M., Fisher, D. A., Cahalane, A. M., & Fintelmann, F. J. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.21.27099 · Cited by 94
Jacob, S., Pathak, A., Franck, D., Latorzeff, I., Jimenez, G., Fondard, O., Lapeyre, M., Colombier, D., Bruguière, É., Lairez, O., et al. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0627-5 · Cited by 99
“Effects of specific doses to the whole heart and to specific cardiac substructures have only been assessed in a few studies [4] [30] that revealed the importance of better knowledge for the effects of radiotherapy to critical structures of the heart, including the effect of both radiation dose and volume of the heart…”
BackgroundGroarke, J. D., Tanguturi, V. K., Hainer, J. M., Klein, J., Moslehi, J. J., Ng, A. K., Forman, D. E., Carli, M. F. D., & Nohria, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.035 · Cited by 98
Cancer as a Risk Factor for Cardiovascular Disease
Giza, D. E., Iliescu, G., Hassan, S. A., Marmagkiolis, K., & Iliescu, C. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0601-x · Cited by 110
Organs at risk radiation dose constraints
Noël, G., & Antoni, D. (2021) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2021.11.001 · Cited by 99
Cardiovascular Considerations Before Cancer Therapy
Raisi‐Estabragh, Z., Murphy, A. C., Ramalingam, S., Scherrer‐Crosbie, M., López‐Fernández, T., Reynolds, K. L., Aznar, M. C., Lin, A. E., Libby, P., Córdoba, R., et al. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.07.017 · Cited by 113
A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology Treatments
Newhauser, W. D., de González, A. B., Schulte, R. W., & Lee, C. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00013 · Cited by 93
“Long-term survivors are at increased risk to develop treatmentinduced side effects, such as radiogenic second cancer, complications of the cardiovascular (10, 11) and central nervous (12, 13) systems, fertility problems (14), and myriad other toxicities (15).”
BackgroundBartlett, F. R., Colgan, R. M., Donovan, E. M., McNair, H. A., Carr, K., Evans, P., Griffin, C. L., Locke, I., Haviland, J., Yarnold, J. R., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.11.018 · Cited by 92
Vaidya, J. S., Bulsara, M. K., Wenz, F. K., Coombs, N. J., Singer, J., Ebbs, S. R., Massarut, S., Saunders, C. M., Douek, M., Williams, N. R., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.05.008 · Cited by 96
“Furthermore, several studies have recently shown that sensitive instruments can detect cardiac effects of radiation therapy within days (18); within months (19); and as shown in a large Oxford overview, certainly within the first 5 years (17).”
BackgroundIs the false-positive rate in mammography in North America too high?
Le, M., Mothersill, C. E., Seymour, C. B., & McNeill, F. E. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160045 · Cited by 96
Gal, R., van Velzen, S. G. M., Hooning, M. J., Emaus, M. J., van der Leij, F., Gregorowitsch, M. L., Blezer, E. L. A., Gernaat, S. A. M., Leßmann, N., Sattler, M. G. A., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1144 · Cited by 96
Space radiation and cardiovascular disease risk
Boerma, M. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i12.882 · Cited by 90
Milo, M. L. H., Offersen, B. V., Bechmann, T., Diederichsen, A. C. P., Hansen, C. R., Holtved, E., Josipović, M., Lörincz, T., Maraldo, M. V., Nielsen, M. H., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.06.015 · Cited by 90
Kim, Y. B., Byun, H. K., Kim, D. Y., Ahn, S., Lee, H., Park, W., Kim, S. S., Kim, J. H., Lee, K. C., Lee, I. J., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6036 · Cited by 90
Optimize and refine therapeutic index in radiation therapy: Overview of a century
Chargari, C., Magné, N., Guy, J., Rancoule, C., Lévy, A., Goodman, K. A., & Deutsch, É. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.03.001 · Cited by 98
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer
Lin, S. H., Zhang, N., Godby, J., Wang, J., Marsh, G. D., Liao, Z. X., Komaki, R. U., Ho, L., Hofstetter, W. L., Swisher, S. G., et al. (2015) · Cancer · doi:10.1002/cncr.29857 · Cited by 89
“Lowdose radiation to the chest for the treatment of lymphoma in young patients can greatly increase the risk of developing future myocardial infarction.12,13 In one SEER analysis of 558,871 women treated for breast cancer, patients with left-sided breast cancer had a higher cardiac mortality ratio that was evident wit…”
BackgroundInsights into the relationships between diabetes, prediabetes, and cancer
Scappaticcio, L., Maiorino, M. I., Bellastella, G., Giugliano, D., & Esposito, K. (2016) · Endocrine · doi:10.1007/s12020-016-1216-y · Cited by 95
A contemporary review of male breast cancer: current evidence and unanswered questions
Leon-Ferre, R. A., Giridhar, K. V., Hieken, T. J., Mutter, R. W., Couch, F. J., Jiménez, R. E., Hawse, J. R., Boughey, J. C., & Ruddy, K. J. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9761-x · Cited by 96
Lai, J., Hu, S., Luo, Y., Zheng, R., Qibao, Z., Chen, P., Chi, B., Zhang, Y., Zhong, F., & Long, X. (2019) · Breast Cancer · doi:10.1007/s12282-019-01023-9 · Cited by 95
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 124
Lin, L. L., Vennarini, S., Dimofte, A., Ravanelli, D., Shillington, K., Batra, S., Tochner, Z. A., Both, S., & Freedman, G. M. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1011756 · Cited by 89
“The mean whole heart dose has been associated with the risk for late cardiac effects [6].”
BackgroundZhao, H., He, M., Cheng, G., Han, D., Wu, N., Shi, D., Zhao, Z., & Jin, J. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0531-4 · Cited by 88
“4 % per gray, with no apparent threshold [20].”
BackgroundDosimetric trade-offs in breast treatment with VMAT technique
Fogliata, A., Seppälä, J., Reggiori, G., Lobefalo, F., Palumbo, V., Rose, F. D., Franceschini, D., Scorsetti, M., & Cozzi, L. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160701 · Cited by 87
How to prevent and manage radiation-induced coronary artery disease
Cuomo, J. R., Javaheri, S. P., Sharma, G. K., Kapoor, D., Berman, A. E., & Weintraub, N. L. (2018) · Heart · doi:10.1136/heartjnl-2017-312123 · Cited by 91
Kreuzer, M., Auvinen, A., Cardis, E., Hall, J., Jourdain, J.-R., Laurier, D., Little, M. P., Peters, A., Raj, K., Russell, N. S., et al. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.03.002 · Cited by 86
“This link has been demonstrated in patients irradiated for Hodgkin’s disease [41], breast cancer [42], and childhood cancer [43].”
BackgroundHowell, R. M., Smith, S. A., Weathers, R. E., Kry, S. F., & Stovall, M. A. (2019) · Radiation Research · doi:10.1667/rr15201.1 · Cited by 89
“While much less established, these types of data are important because they add to the body of epidemiologic literature on the relationship between radiation and cardiac effects (46, 47, 56), which thus far have used only average heart dose.”
BackgroundZamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0156 · Cited by 86
“The most exposed coronaries are the left anterior descending during left breast irradiation and the left main stem, circumflex and right coronary arteries during treatment for Hodgkin lymphoma.(132,133) A higher prevalence of stress test abnormalities has been found among women irradiated for left breast cancer compar…”
BackgroundRadiation on Earth or in Space: What Does It Change?
Restier-Verlet, J., Nachef, L. E., Ferlazzo, M. L., Al-Choboq, J., Granzotto, A., Bouchet, A., & Foray, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073739 · Cited by 93
Lopez‐Mattei, J., Yang, E. H., Baldassarre, L. A., Agha, A. M., Blankstein, R., Choi, A., Chen, M. Y., Meyersohn, N. M., Daly, R. P., Slim, A. M., et al. (2022) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2022.09.002 · Cited by 88
Cardiovascular Considerations After Cancer Therapy
Blaes, A. H., Nohria, A., Armenian, S. H., Bergom, C. R., Thavendiranathan, P., Barac, A., Sanchez‐Petitto, G., Desai, S., Zullig, L. L., Morgans, A. K., et al. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.06.006 · Cited by 100
Cardiac Effects of Anticancer Therapy in the Elderly
Accordino, M. K., Neugut, A. I., & Hershman, D. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0459 · Cited by 85
“The average cardiac RT doses were 1.37 Gy for supine-positioned RT and were less in pronepositioned RT compared with 4.6 Gy in the study by Darby et al.69 The authors reported that the predicted lifetime risks of major coronary events as a result of RT are expected to decrease with the use of modern techniques.70”
BackgroundInfluentialTseng, Y. D., Cutter, D. J., Plastaras, J. P., Parikh, R. R., Cahlon, O., Chuong, M. D., Dědečková, K., Khan, M. K., Lin, S.-Y., McGee, L. A., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.05.004 · Cited by 90
Self-citationArterial Thrombosis in Patients with Cancer
Tuzovic, M., Herrmann, J., Iliescu, C., Marmagkiolis, K., Ziaeian, B., & Yang, E. H. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0635-x · Cited by 91
Abdel-Qadir, H. M., Thavendiranathan, P., Austin, P. C., Lee, D. S., Amir, E., Tu, J. V., Fung, K., & Anderson, G. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy218 · Cited by 91
Kirwan, C., Coles, C. E., Bliss, J., Kirwan, C., Kilburn, L., Fox, L., Cheang, M. C. U., Griffin, C., Francis, A., Kirby, A. M., et al. (2016) · Clinical Oncology · doi:10.1016/j.clon.2016.06.007 · Cited by 85
“4% per Gray mean heart dose, with the absolute risk of radiationinduced cardiac toxicity increasing substantially in patients with pre-existing cardiac risk factors [5].”
BackgroundDemissei, B. G., Freedman, G. M., Feigenberg, S. J., Plastaras, J. P., Maity, A. M., Smith, A. M., McDonald, C., Sheline, K., Simone, C. B., Lin, L. L., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.11.013 · Cited by 84
“We found (1) significant increases in PIGF and GDF-15 levels after completion of RT compared to pre-RT, particularly in patients with lung cancer or mediastinal lymphoma; (2) significant associations between MHD and other cardiac dosimetry variables such as V5 and V30, and changes in PIGF and GDF-15 after completion o…”
BackgroundMethodInfluentialHeart dose reduction by prone deep inspiration breath hold in left-sided breast irradiation
Mulliez, T., Veldeman, L., Speleers, B., Mahjoubi, K., Remouchamps, V. M., Greveling, A. V., Gilsoul, M., Berwouts, D., Lievens, Y. N., den Broecke, R. V., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.11.038 · Cited by 89
Long-term Toxicity of Cancer Treatment in Older Patients
Shahrokni, A., Wu, A. J.-C., Carter, J., & Lichtman, S. M. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.08.005 · Cited by 88
Kaderka, R., Gillespie, E. F., Mundt, R. C., Bryant, A. K., Sanudo-Thomas, C. B., Harrison, A. L., Wouters, E. L., Moiseenko, V., Moore, K. L., Atwood, T. F., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.07.013 · Cited by 84
Regional Nodal Irradiation in Early-Stage Breast Cancer
Mulliez, T., Veldeman, L., & Neve, W. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1510505 · Cited by 84
Boekel, N. B., Jacobse, J. N., Schaapveld, M., Hooning, M. J., Gietema, J. A., Duane, F. K., Taylor, C. W., Darby, S. C., Hauptmann, M., Seynaeve, C., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0159-x · Cited by 88
Self-citationGaál, S., Kahán, Z., Paczona, V., Kószó, R., Drencsényi, R., Szabó, J., Rónai, R., Antal, T., Deák, B., & Varga, Z. (2021) · Radiation Oncology · doi:10.1186/s13014-021-01816-3 · Cited by 88
“4% that may be potentiated by preexisting cardiovascular risk factors [6, 11] and smoking [8].”
BackgroundThorsen, L. B. J., Thomsen, M. S., Berg, M., Jensen, I., Josipović, M., Overgaard, M., Overgaard, J., Skogholt, P., & Offersen, B. V. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.925579 · Cited by 84
“The model for ischemic heart death after breast cancer rT was developed in a large case control study of Danish and swedish breast cancer patients treated with rT as early as 1958 up to 2001 [8].”
BackgroundMethodInfluentialWu, A. H., Kurian, A. W., Kwan, M. L., John, E. M., Lu, Y., Keegan, T. H. M., Gomez, S. L., Cheng, I. C., Shariff‐Marco, S., Caan, B. J., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1140 · Cited by 85
Pericardial Disease in Cancer Patients
Ghosh, A. K., Crake, T., Manisty, C., & Westwood, M. A. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0654-7 · Cited by 83
Corradini, S., Ballhausen, H., Weingandt, H., Freislederer, P., Schönecker, S., Niyazi, M., Simonetto, C., Eidemüller, M., Ganswindt, U., & Belka, C. (2017) · Strahlentherapie und Onkologie · doi:10.1007/s00066-017-1213-y · Cited by 87
Metadata
- Authors
- Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.-B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., & Hall, P.
- Affiliations
- University of Oxford (GB)
- University of Southern Denmark (DK)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Aalborg University Hospital (DK)
- University of South Florida (US)
- Danderyds sjukhus (SE)
- Rigshospitalet (DK)
- Royal Surrey County Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 987-998
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154375587
- Cited by
- 3,974
- References
- 38
- Citations by year
- 2026: 277 · 2025: 290 · 2024: 270 · 2023: 358 · 2022: 359 · 2021: 392 · 2020: 344 · 2019: 285 · 2018: 278 · 2017: 268 · 2016: 285 · 2015: 259 · 2014: 195 · 2013: 107
- FWCI
- 191.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK
- National Institute for Health and Care Research (RRX 108)
- British Heart Foundation (RE/08/004, CRE RE/08/004)
- University of Oxford (RE/08/004)
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- breast cancer radiotherapy, ischemic heart disease, coronary events, myocardial infarction, coronary revascularization, radiation-induced heart disease, left anterior descending artery, radiation dose, cardiovascular risk factors, women
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, Heart, Humans, Mastectomy, Middle Aged, Radiation Injuries, Radiotherapy Dosage, Risk, Risk Factors, Case-Control Studies, Chemotherapy, Adjuvant, Myocardial Ischemia, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.